Bauer, Wolfgang R.

Boerdlein, Annegret

Maier, Sebastian K.G.

Ong, Peter

Paul, Vince

Proff, Jochen

Sack, Stefan

Shanmugam, Nesan

Valencia, Oswaldo

EP Europace

English

PubMed

N. Shanmugam

A. Boerdlein

J. Proff

P. Ong

O. Valencia

S. K. G. Maier

W. R. Bauer

V. Paul

S. Sack

Crossref

Detection of atrial high-rate events by continuous Home Monitoring: clinical significance in the heart failure-cardiac resynchronization therapy population

A comparison of rate control and rhythm control in patients with atrial ﬁbrillation.

Accuracy of atrial tachyarrhythmia detection in implantable devices with arrhythmia therapies. Pacing Clin Electrophysiol

Atrial ﬁbrillation is under-recognized in chronic heart failure: insights from a heart failure cohort treated with cardiac resynchronization therapy.

Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST). Circulation

Clinical importance of new-onset atrial ﬁbrillation after cardiac resynchronization therapy. Heart Rhythm

Clinical utility of intraatrial pacemaker stored electrograms to diagnose atrial ﬁbrillation and ﬂutter. Pacing Clin Electrophysiol

Device-detected atrial tachyarrhythmias predict adverse outcome in real-world patients with implantable biventricular deﬁbrillators.

Effect of cardiac resynchronization on the incidence of atrial ﬁbrillation in patients with severe heart failure. Circulation

Efﬁ-cacy and safety of automatic remote monitoring for implantable cardioverterdeﬁbrillator follow-up: the Lumos-T Safely Reduces Routine Ofﬁce Device Follow-up (TRUST) trial.

for Chronic conditions. Atrial ﬁbrillation: national clinical guideline for the management in primary and secondary care.

Guidelines for the management of atrial ﬁbrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

Impact of atrial ﬁbrillation on the risk of death: the Framingham Heart Study. Circulation

Left atrial mechanical function after brief duration atrial ﬁbrillation.

Long-term risk of recurrent atrial ﬁbrillation as documented by an implantable monitoring device: implications for optimal patient care.

Monitored atrial ﬁbrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial ﬁbrillation implanted with antitachycardia pacemakers.

Multicenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with implantable cardioverter-deﬁbrillator and CRT-D devices: rationale, design, and clinical characteristics of the initially enrolled cohort The IMPACT study.

Presence and duration of atrial ﬁbrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events.

Stroke with intermittent atrial ﬁbrillation: incidence and predictors during aspirin therapy. Stroke prevention in atrial ﬁbrillation investigators.

The relationship between atrial high-rate episodes and stroke: the Asymptomatic Stroke and Atrial Fibrillation Evaluation in Pacemaker Patients (ASSERT) trial.

The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study.

TRENDS Investigators, The temporal relationship of atrial tachyarrhythmias, cerebrovascular events, and systemic emboli based on stored device data: a subgroup analysis of TRENDS. Heart Rhythm 2011;8:1416–23.

Validation of clinical classiﬁcation schemes for predicting stroke: results from the National Registry of Atrial Fibrillation.

Value of routine Holter monitoring for the detection of paroxysmal atrial ﬁbrillation in patients with cerebral ischemic events. Stroke

wireless, ambulatory monitoring of implantable pacemakers, cardioverter deﬁbrillators, and cardiac resynchronization therapy systems: analysis of a worldwide database. Pacing Clin Electrophysiol 2007; 30(Suppl 1):S2–12.

http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3262405

Detection of atrial high-rate events by continuous Home Monitoring: clinical significance in the heart failure–cardiac resynchronization therapy population

Detection of atrial high-rate events by continuous Home Monitoring: clinical significance in the heart failure–cardiac resynchronization therapy population

Abstract

Similar works

Full text

Available Versions

Crossref